Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy

Published:2013-07-09 Issue:12 Volume:20 Page:1539-1545
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Lozeron P.¹²,Théaudin M.¹²³,Mincheva Z.¹²,Ducot B.⁴,Lacroix C.²⁵,Adams D.¹²³,

Affiliation:

1. Department of Neurology; APHP, CHU de Bicêtre; Le Kremlin Bicêtre France

2. APHP, CHU de Bicêtre, French national reference centre for FAP (NNERF); Le Kremlin Bicêtre France

3. INSERM U788; APHP, CHU de Bicêtre; Le Kremlin Bicêtre France

4. INSERM Unité 822, IFR69; INED; APHP, CHU de Bicêtre; Le Kremlin Bicêtre France

5. Department of Neuropathology; APHP, CHU de Bicêtre; Le Kremlin Bicêtre France

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12225/fullpdf

Reference26 articles.

1. Hereditary and acquired amyloid neuropathies;Adams;J Neurol,2001

2. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis;Holmgren;Lancet,1993

3. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation;Adams;Brain,2000

4. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years;Yamamoto;Am J Transplant,2007

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real life experience of tafamidis for the treatment of Spanish patients with Val30Met transthyretin amyloidosis with polyneuropathy;Medicina Clínica;2024-05

2. Real life experience of tafamidis for the treatment of Spanish patients with Val30Met transthyretin amyloidosis with polyneuropathy;Medicina Clínica (English Edition);2024-05

3. Treatment of ATTR Amyloidosis: From Stabilizers to Gene Editing;Cardiac Amyloidosis;2024

4. Disease‐Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy;Annals of Neurology;2023-12-23

5. Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatments;Blood;2023-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3